Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Eduardo Terreros"'
Autor:
Svetlana V. Doubova, Eduardo Terreros-Muñoz, Nancy Delgado-Lòpez, Efreen Horacio Montaño-Figueroa, Claudia Infante-Castañeda, Ricardo Pérez-Cuevas
Publikováno v:
BMC Health Services Research, Vol 20, Iss 1, Pp 1-10 (2020)
Abstract Background In Mexico, patients with hematologic malignancies (HMs) are characterized by being at high risk and advanced stages at diagnosis and by having a low cure rate; yet information on their experiences with health care and health-relat
Externí odkaz:
https://doaj.org/article/8882e4f6582d40348c039c76a8eb5657
Autor:
Ruben Solis-Armenta, Andrea Priscila Hernandez Perez, Nidia Paulina Zapata, Nancy Delgado, Efreen H Montano Figueroa, Faustino . Leyto, Juan Carlos Solís-Poblano, Andres Gomez-De Leon, Lauro Fabian Amador, Carolina García-Castillo, Ramon Martinez Hernandez, Hugo Alexis Saldaña Velázquez, Espinoza Ramiro, Victor Itaí Urbalejo Ceniceros, Valentín Lozano-Zavaleta, Eduardo Terreros, Mark A. Jiménez, Andrea Milan Salvatierra, Perla Rocio Colunga Pedraza, David Gomez-Almaguer, Luisa M Alcivar, Elia Apodaca Chavez, Mario Meza, Fabiola Yocupicio, Susana Sánchez-Díaz, Rafael Lope-Herrera, Roberta Demichelis
Publikováno v:
Blood. 140:10830-10832
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ba9e211334f7cef55d68731276c95925
https://doi.org/10.1182/blood-2022-170200
https://doi.org/10.1182/blood-2022-170200
Autor:
Eduardo Terreros-Muñoz, Nancy Delgado-Lopez, Claudia Infante-Castañeda, Ricardo Pérez-Cuevas, Efreen Horacio Montaño-Figueroa, Svetlana V. Doubova
Publikováno v:
BMC Health Services Research, Vol 20, Iss 1, Pp 1-10 (2020)
BMC Health Services Research
BMC Health Services Research
Background In Mexico, patients with hematologic malignancies (HMs) are characterized by being at high risk and advanced stages at diagnosis and by having a low cure rate; yet information on their experiences with health care and health-related qualit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a460bd242bde20e4f3624c1ff35436db
http://link.springer.com/article/10.1186/s12913-020-05498-7
http://link.springer.com/article/10.1186/s12913-020-05498-7
Autor:
Svetlana Vladislavovna Doubova, Eduardo Terreros-Muñoz, Nancy Delgado-Lòpez, Efreen Horacio Montaño-Figueroa, Claudia Infante-Castañeda, Ricardo Perez Cuevas
Background: In Mexico, patients with hematologic malignancies (HMs) are characterized by being at high risk and advanced stages at diagnosis and by having a low cure rate; yet information on their experiences with health care and health-related quali
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::93b4e25bba92958da923c8b0958405e8
https://doi.org/10.21203/rs.3.rs-29181/v2
https://doi.org/10.21203/rs.3.rs-29181/v2
Autor:
Álvaro Cabrera-García, Lauro Fabián Amador-Medina, Roberta Demichelis-Gómez, David Gómez-Almaguer, Karla Espinosa-Bautista, Juan Carlos Solís-Poblano, Ramiro Espinoza, Lilia Adela García-Stivalet, Efreen Horacio Montaño-Figueroa, Carolina Moreira, Nidia Zapata-Canto, Erick Crespo-Solís, Etta Rozen-Fuller, Alva Zaragoza, Ramón Alejandro Martínez-Hernández, Ruth Gutiérrez-Serdán, Carolina García-Castillo, Angel Carrillo, Faustino Leyto-Cruz, Alejandro Limon, Francisco Turrubiates, Eduardo Terreros-Muñoz, Luis Meillon, Perla R. Colunga-Pedraza, Elia Ixel Apodaca, Guillermo Diaz-Vargas
Publikováno v:
Clinical lymphoma, myelomaleukemia. 20(6)
Background In the past decades, long-term survival outcomes for younger patients with acute myeloid leukemia (AML) have improved. Nonetheless, developing nations might be lagging behind, highlighting the need to assess real-world outcomes in such reg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::389c5039eb82b846679c77880a89981a
https://pubmed.ncbi.nlm.nih.gov/32192977
https://pubmed.ncbi.nlm.nih.gov/32192977
Autor:
Peter A. Cooper, Dominick Amato, Sergio Solorio-Meza, Fiorina Giona, Ari Zimran, Eduardo Terreros Muñoz, Atul Mehta, Sheeba Varughese, Raul Chertkoff, Hanna Rosenbaum, Gloria Duran, Milan Petakov, Einat Brill-Almon, Pilar Giraldo
Publikováno v:
American Journal of Hematology
Taliglucerase alfa is an intravenous enzyme replacement therapy approved for treatment of type 1 Gaucher disease (GD), and is the first available plant cell-expressed recombinant therapeutic protein. Herein, we report long-term safety and efficacy re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f44d033a6bd94b759c5a6e6a7b287c7b
https://doi.org/10.1002/ajh.24369
https://doi.org/10.1002/ajh.24369
Autor:
Carolina García, Eduardo Terreros, Roberta Demichelis, Elia Ixel Apodaca, Karla Espinosa, Perla Colunga, Ramiro Espinoza, Carolina Moreira, Guillermo Díaz, Ruth Gutiérrez, Ramón Martínez, Erick Crespo, David Gómez, Angel Carrillo, Francisco Turrubiates, Faustino Leyto, Alva Zaragoza, Luis Meillón, Etta Rozen, Juan_Carlos Solis, Nidia Zapata, Álvaro Cabrera, Fabián Amador, Alejandro Limon, Efreen Montaño, Lilia García
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 19:S209-S210
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::83c2349511939fb2c2184a0f56ccd131
https://doi.org/10.1016/j.clml.2019.07.074
https://doi.org/10.1016/j.clml.2019.07.074
Autor:
Jesús, Medrano-Contreras, Juan Osvaldo, Talavera-Piña, Susana, Guerrero-Rivera, Guillermo Rodolfo, Gutiérrez-Espíndola, Cynthia, Gómez-Cortés, Juan Fernando, Pérez-Rocha, Eduardo, Terreros-Muñoz, Luis Antonio, Meillón-García
Publikováno v:
Revista medica del Instituto Mexicano del Seguro Social. 54
The use of high-intensity chemotherapy (HIC) for acute myeloid leukemia (AML) in the elderly is controversial. In the present study, it was assessed complete remission and overall survival of AML patients over 60 years treated with HIC or palliative
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::11a8cb4355ebb833cc103f9f435ba849
https://pubmed.ncbi.nlm.nih.gov/27561018
https://pubmed.ncbi.nlm.nih.gov/27561018
Autor:
Peter A. Cooper, Hanna Rosenbaum, Sari Alon, Gloria Duran, Milan Petakov, Ari Zimran, Sergio Solorio-Meza, Fiorina Giona, Raul Chertkoff, Eduardo Terreros Muñoz, Pilar Giraldo, Sheeba Varughese
Taliglucerase alfa, the first available plant cell–expressed recombinant therapeutic protein, is an enzyme replacement therapy approved for Gaucher disease (GD). PB-06-001, a pivotal phase 3, multicenter, randomized, double-blind, parallel-dose stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a562bab1c6cc46ccb1068793257c8b6b
http://hdl.handle.net/11573/910808
http://hdl.handle.net/11573/910808
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.